Niki BioSolutions, Inc. (NIKI) Net Income towards Common Stockholders (2017 - 2025)

Niki BioSolutions (NIKI) has 3 years of Net Income towards Common Stockholders data on file, last reported at $1.2 million in Q4 2025.

• Quarterly Net Income towards Common Stockholders rose 1186.38% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $644292.0 (up 328.04% YoY) and the FY2025 annual result came in at -$1.5 million, down 136.2% from the prior year.
• Net Income towards Common Stockholders grew to $1.2 million in Q4 2025, from -$744403.0 in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.2 million in Q4 2025 to a low of -$744403.0 in Q3 2025.